Baloxavir and Oseltamivir for the Treatment of Severe Influenza Infection in Immunocompromised Patients
Conditions: Hematopoietic and Lymphoid Cell Neoplasm; Influenza Interventions: Drug: Baloxavir Marboxil; Drug: Oseltamivir Sponsor: M.D. Anderson Cancer Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 15, 2021 Category: Research Source Type: clinical trials
A Study of ZSP1273 Tablets in Patients With Acute Uncomplicated Influenza A
Condition: Influenza A Interventions: Drug: ZSP1273 600 mg; Drug: Placebo to Oseltamivir; Drug: Oseltamivir(oral); Drug: Placebo to ZSP1273 Sponsor: Guangdong Raynovent Biotech Co., Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 24, 2020 Category: Research Source Type: clinical trials